These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1309068)

  • 1. Prolonged coagulation instability is associated with a higher-dose regimen of tissue-type plasminogen activator in patients with acute myocardial infarction.
    Andreotti F; Kluft C; Davies GJ; Hackett DR; Prevost R; Maseri A
    Ann N Y Acad Sci; 1992 Dec; 667():450-3. PubMed ID: 1309068
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
    Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
    Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefical effects of reteplase in combination with abciximab: platelet/leukocyte interactions and coagulation system.
    Szabo S; Walter T; Etzel D; Ehlers R; Kazmaier S; Beyer ME; Hoffmeister HM
    Int J Clin Pharmacol Res; 2003; 23(2-3):37-40. PubMed ID: 15018016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
    Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarction.
    Barbash GI; Hod H; Rath S; Miller HI; Roth A; Har-Zahav Y; Modan M; Rotstein Z; Batler A; Zivelin A
    Am J Cardiol; 1989 Jul; 64(3):225-8. PubMed ID: 2500841
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
    Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
    Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator.
    Fassbender K; Dempfle CE; Mielke O; Schwartz A; Daffertshofer M; Eschenfelder C; Dollman M; Hennerici M
    Stroke; 1999 Oct; 30(10):2101-4. PubMed ID: 10512913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
    Mitusch R; Siemens HJ; Garbe M; Wagner T; Sheikhzadeh A; Diederich KW
    Thromb Haemost; 1996 Feb; 75(2):219-23. PubMed ID: 8815563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.
    Pedersen OD; Gram J; Jespersen J
    Heart; 1997 Feb; 77(2):122-7. PubMed ID: 9068393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation after fast or prolonged regimens of tissue-type plasminogen activator.
    Andreotti F; Kluft C; Hackett DR; Davies GJ; Maseri A
    Lancet; 1993 Oct; 342(8876):937-8. PubMed ID: 8105201
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in systemic fibrinolysis and blood coagulation parameters in local thrombolysis with tissue plasminogen activator (rt-PA)].
    Klein P; Roth FJ; Rieger H; Popov-Cenic S
    Vasa; 1992; 21(3):249-52. PubMed ID: 1529628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variations in hemostasis and fibrinolysis during the treatment of acute myocardial infarct (AMI) with tissue-type plasminogen activator (TTPA). A study of 17 cases].
    Izaguirre Avila R; Ruiz de Chávez Cervantes A; Villavicencio R; Gómez Trigos A; Mar Chavira R; Spíndola Mdel C; Casanova JM
    Arch Inst Cardiol Mex; 1993; 63(3):235-40. PubMed ID: 8347053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor- and kringle 1-domains.
    Emeis JJ; Verheijen JH
    Ann N Y Acad Sci; 1992 Dec; 667():421-3. PubMed ID: 1309064
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Henkin J
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of coagulation and fibrinolysis during treatment with OKT3.
    ten Berge RJ; Raasveld MH; van Diepen FN; Hack CE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):566-7. PubMed ID: 8438416
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction.
    McNeill AJ; Shannon JS; Cunningham SR; Flannery DJ; Campbell NP; Khan MM; Patterson GC; Webb SW; Adgey AA
    Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1768-71. PubMed ID: 3136831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.